亚洲 · 区域市场 · Pulse (Maeil Business)
U.S. cancer genomics firm Inocras clears key hurdle for Kosdaq listing
Inocras Inc., a U.S.-based precision cancer genomics diagnostics company, has passed the technology assessment required for a special-track listing on South Korea’s secondary…
在 Pulse (Maeil Business) 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (pulse.mk.co.kr)
